Biocon Limited is an Indian biopharmaceutical company based in Bangalore, India. The Company manufactures generic active pharmaceutical ingredients that are sold in over 120 countries across the globe, including the developed markets of the United States and Europe. Read More
Biocon Biologics has partnered with the International Diabetes Federation (IDF) as the first biosimilar insulin company to promote and support IDF's core mission initiative and activities. ...
Abu Dhabi-based ADQ will invest Rs 555 crore for 1.8 per cent minority stake in Biocon Biologics, valuing it at a post money valuation of 4.17 billion dollars (about Rs 30,482 crore). ...
Leading biotechnology company Biocon on Thursday reported a net profit of Rs 203 crore for the third quarter (October-December) of fiscal 2019-20, declining by 7 per cent compared to Rs 217 crore in the same quarter last year. ...
Biopharmaceuticals major Biocon said on Monday the board of its subsidiary Biocon Biologics has approved a primary equity investment by True North which will invest Rs 536.25 crore to pick 2.44 per cent minority stake in the biosimilars business. ...